06/04/2019
Nobuyuki Takahashi, MD; Tarun Chakravarty, MD; Rahul P. Sharma, MD, MBBS, FRACP; Hasan Jilaihawi, MBChB, MD; Raj R. Makkar, MD; Sung-Han Yoon, MD; Mamoo Nakamura, MD; Yoshio Maeno, MD, PhD; Yigal Abramowitz, MD; Sharjeel Israr, MD; Shunsuke Kubo, MD; Takahiro Nomura, MD, PhD; Masaki Miyasaka, MD; Hiroyuki Kawamori, MD, PhD; Yoshio Kazuno, MD
Abstract
Background. Data are limited regarding the clinical impact of permanent pacemaker implantation (PPI) in patients with low left ventricular ejection fraction (LVEF) after transcatheter aortic valve replacement (TAVR). The aim of this...
Abstract
Background. Data are limited regarding the clinical impact of permanent pacemaker implantation (PPI) in patients with low left ventricular ejection fraction (LVEF) after transcatheter aortic valve replacement (TAVR). The aim of this...
Abstract
Background. Data are...